Avandia
NDC Package 0029-3159-61

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Avandia is rosiglitazone is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Marketed by Glaxosmithkline Llc, this product is identified by NDC 0029-3159 and is authorized under FDA application NDA021071.

Identification & Billing

NDC Package Code
0029-3159-61
Package Description
7 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00029315961

Clinical Specifications

Proprietary Name
Avandia
Dosage Form
-
Usage Information
Rosiglitazone is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Rosiglitazone belongs to the class of drugs known as glitazones. It lowers blood sugar by helping to restore your body's proper response to insulin.

Regulatory & Marketing

Labeler Name
Glaxosmithkline Llc
FDA Application #
NDA021071
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-29-1999
End Marketing Date
11-18-2011
Listing Expiration
11-18-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0029-3159). Click a package code to view its specific billing and regulatory data.

90 TABLET, FILM COATED in 1 BOTTLE
30 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0029-3159-61 identifies a specific commercial package of 7 tablet, film coated in 1 blister pack of Avandia, labeled by Glaxosmithkline Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Llc on May 29, 1999. The current certification is valid through November 18, 2011.

What are the primary indications for this medication?

Rosiglitazone is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Rosiglitazone belongs to the class of drugs known as glitazones. It lowers blood sugar by helping to restore your body's proper response to insulin.

How is this Glaxosmithkline Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00029315961. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0029-3159-61
11-Digit CMS (5-4-2)
00029-3159-61

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.